Agro Chemicals · DAGRI
Pesticides/Agrochemicals
from 1,027 today
Dhanuka Agritech reported a muted 1QFY27 performance with revenue, EBITDA, and PAT declining YoY, leading management to lower its FY27 revenue guidance. However, the company maintains a BUY rating with a target price of INR 1,260, expecting a recovery in ensuing quarters led by bio-stimulant portfolio revenue, monsoon pick-up, and volume growth on a low base.
Dhanuka Agritech reported a weak Q1FY27 performance due to a delayed monsoon and weak herbicide demand, leading the company to downgrade its FY27 guidance. However, management remains optimistic about medium-term recovery and long-term growth driven by new product launches, the Nagpur capex, and international expansion of Bayer fungicide brands.
We initiate coverage on Dhanuka Agritech Limited DAGRI with a BUY rating and a target price of Rs 1,350, based on ~18x FY28E EPS, implying an upside of ~31%. DAGRI is one of India's leading branded crop-protection formulation companies, with a pan-India distribution network of over 10mn farmers.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
